Imaging-derived Biomarkers Associated with Atrial FIBROsis, Structural Remodeling and the Risk of Cardioembolic Events in Patients with Atrial Fibrillation – the FIBROS Study

1. Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114:119-125.10.1161/CIRCULATIONAHA.105.595140Search in Google Scholar

2. Chamberlain AM, Gersh BJ, Alonso A, et al. Decade-long trends in atrial fibrillation incidence and survival: a community study. Am J Med. 2015;128:260-267.10.1016/j.amjmed.2014.10.030Search in Google Scholar

3. Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129:837-847.10.1161/CIRCULATIONAHA.113.005119Search in Google Scholar

4. Benjamin J. Hirsh, MD, Robert S, et al. Fibrotic Atrial Cardiomyopathy, Atrial Fibrillation, and Thromboembolism. Elsevier. 2015;65:2239-2251.10.1016/j.jacc.2015.03.557Search in Google Scholar

5. Disertori M, Franzosi MG, Barlera S, et al. Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: data from the GISSIAF trial. BMC Cardiovasc Disord. 2013;13:28.10.1186/1471-2261-13-28Search in Google Scholar

6. Steinberg BA, Hellkamp AS, Lokhnygina Y, et al. Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF trial. Eur Heart J. 2015;36:288-296.10.1093/eurheartj/ehu359Search in Google Scholar

7. Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366:120-129.10.1056/NEJMoa1105575Search in Google Scholar

8. Haemers P, Hamdi H, Guedj K, et al. Atrial fibrillation is associated with the fibrotic remodelling of adipose tissue in the subepicardium of human and sheep atria. Eur Heart J. 2017;38:53-61.10.1093/eurheartj/ehv625Search in Google Scholar

9. Auer J. Fat: an emerging player in the field of atrial fibrillation. Eur Heart J. 2017;38:62-65.10.1093/eurheartj/ehw013Search in Google Scholar

10. Luscher FT. Atrial fibrillation beyond the arrhythmia: hypercoagulability, adipose tissue, and fibrotic remodeling. Eur Heart J. 2017;38:1-3.10.1093/eurheartj/ehw674Search in Google Scholar

11. Nattel S, Harada M. Atrial remodeling and atrial fibrillation: recent advances and translational perspectives. J Am Coll Cardiol. 2014;63:2335-2345.10.1016/j.jacc.2014.02.555Open DOISearch in Google Scholar

12. Tan AY, Zimetbaum P. Atrial fibrillation and atrial fibrosis. J Cardiovasc Pharmacol. 2011;57:625-629.10.1097/FJC.0b013e3182073c78Search in Google Scholar

13. Mikhail S. Dzeshka, Gregory Y.H. Lip, et al. Cardiac Fibrosis in Patients With Atrial Fibrillation. JACC. 2015;66:943-959.10.1016/j.jacc.2015.06.1313Search in Google Scholar

14. Filgueiras-Rama D, Price NF, Martins RP, et al. Long-term frequency gradients during persistent atrial fibrillation in sheep are associated with stable sources in the left atrium. Circ Arrhythm Electrophysiol. 2012;5:1160-1167.10.1161/CIRCEP.111.969519Search in Google Scholar

15. Gramley F, Lorenzen J, Jedamzik B, et al. Atrial fibrillation is associated with cardiac hypoxia. Cardiovasc Pathol. 2010;19:102-111.10.1016/j.carpath.2008.11.001Open DOISearch in Google Scholar

16. Steffel J, Luscher TF, Tanner FC. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation. 2006;113:722-731.10.1161/CIRCULATIONAHA.105.567297Search in Google Scholar

17. Daccarett M, Badger TJ, Akoum N, et al. Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation. J Am Coll Cardiol. 2011;57:831-838.10.1016/j.jacc.2010.09.049Open DOISearch in Google Scholar

18. Spragg DD, Khurram I, Nazarian S. Role of Magnetic Resonance Imaging of Atrial Fibrosis in Atrial Fibrillation Ablation. Arrhythm Electrophysiol Rev. 2013;2:124-127.10.15420/aer.2013.2.2.124Search in Google Scholar

19. Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation. 2001;104:2886-2891.10.1161/hc4901.101760Open DOISearch in Google Scholar

20. Mihm MJ, Yu F, Carnes CA, et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation. 2001;104:174-180.10.1161/01.CIR.104.2.174Open DOISearch in Google Scholar

21. Conen D, Ridker PM, Everett BM, et al. A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women. Eur Heart J. 2010;31:1730-1736.10.1093/eurheartj/ehq146Open DOISearch in Google Scholar

22. Jesel L, Arentz T, Herrera-Siklody C, et al. Do atrial differences in endothelial damage, leukocyte and platelet activation, or tissue factor activity contribute to chamber-specific thrombogenic status in patients with atrial fibrillation?. J Cardiovasc Electrophysiol. 2014;25:266-270.10.1111/jce.12312Search in Google Scholar

23. Akar JG, Jeske W, Wilber DJ. Acute onset human atrial fibrillation is associated with local cardiac platelet activation and endothelial dysfunction. J Am Coll Cardiol. 2008;51:1790-1793.10.1016/j.jacc.2007.11.083Open DOISearch in Google Scholar

24. Pathak RK, Mahajan R, Lau DH, Sanders P. The implications of obesity for cardiac arrhythmia mechanisms and management. Can J Cardiol. 2015;31:203-210.10.1016/j.cjca.2014.10.027Search in Google Scholar

25. Abed HS, Samuel CS, Lau DH, et al. Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation. Heart Rhythm. 2013;10:90-100.10.1016/j.hrthm.2012.08.043Search in Google Scholar

26. Steffel J, Luscher TF, Tanner FC. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation. 2006;113:722-731.10.1161/CIRCULATIONAHA.105.567297Search in Google Scholar

27. Spronk HM, De Jong AM, Verheule S, et. al. Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation. Eur Heart J. 2017;38:38-50.10.1093/eurheartj/ehw119Open DOISearch in Google Scholar

28. Olesen JB, Torp-Pedersen C, Hansen ML, Lip GY. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study. Thromb Haemost. 2012;107:1172-1179.10.1160/TH12-03-0175Search in Google Scholar

29. Hirsh BJ, Copeland-Halperin RS, Halperin JL. Fibrotic atrial cardiomyopathy, atrial fibrillation, and thromboembolism: mechanistic links and clinical inferences. J Am Coll Cardiol. 2015;65:2239-2251.10.1016/j.jacc.2015.03.557Search in Google Scholar